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Introduction
Cerebral palsy (CP) is an umbrella term applied to a
group of motor disorders of central origin defined by
clinical description [1]. CP is a permanent, but not
unchanging disorder of movement or motor function
and/or posture, due to a non-progressive interference,
lesion or abnormality in the developing brain [2].
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Abstract: Cerebral palsy (CP) is a common cause of motor deficiency in children born prematurely. The present
study explored the effect of biographical factors on study measures; determined whether performance on neuro-
sensory motor developmental assessment (NSMDA) at 8, 12 and 24 months in prematurely born children with CP
predicted performance at the age of 4 years; and investigated the percentage of children within each NSMDA
classification at each test age who were walking independently at the age of 4 years. Forty-three children born
prematurely and diagnosed with CP by the age of 4 years were assessed on NSMDA. Regression analyses
showed that NSMDA at 8 months was predictive of classification at 12 months (r2(1) = 10.3, p = 0.001, OR = 2.6,
95% CI = 1.45, 4.66); at 12 months predicted classification at 2 years (r2(1)
 
= 12.2, p = 0.000, OR = 4.15, 95% CI
= 1.86, 9.2); and at 2 years predicted classification at 4 years (r2(1)
 
= 8.2, p = 0.004, OR = 4.7, 95% CI = 1.63, 13.87).
All children with normal, minimal and mild NSMDA classifications at 12 months were independently walking at
4 years. NSMDA provides useful information regarding the outcome of children with CP from 8 months.
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CP, therefore, provides very little information about
pathology, aetiology or prognosis [1]. Worldwide, CP is
considered the most common cause of motor deficiency
in young children, occurring in two to three of every
1,000 live births [2]. There is an increase in the risk of
CP with decreasing gestation at delivery [3] and, in a
population-based study of CP, investigators noted that
low birth weight is strongly associated with CP [4].
©2005 Elsevier. All rights reserved.
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Clinical physiotherapists are aware of the profound
variability in the presentation of children with a
diagnosis of CP, and particularly of the difficulty in
diagnosing the condition in children born prematurely
[5]. Physiotherapists also recognise that children with
CP may demonstrate variable changes in motor function
with age and development [6]. Despite this variability,
it is apparent that there may be a relationship between
early motor performance and later outcome.
The development of the Gross Motor Function
Classification System (GMFCS) by Palisano et al [7], has
become the principal classification system for the
evaluation of gross motor ability in children with CP
aged 2–12 years [8]. The GMFCS is a predictive tool that
evaluates self-initiated gross motor abilities, which can
assist parents and health-care professionals to make
more effective evidence-based management decisions,
with respect to the functional performance of the child
with CP [9].
Families of infants with high risk or with CP
frequently ask the physiotherapist about the prognosis
of their child’s ambulatory and prehensile ability.
Therefore, physiotherapists evaluate high-risk infants
and children with CP younger than 2 years of age and
find that neuro-sensory motor developmental
assessment (NSMDA) is a valuable tool [10,11]. The
NSMDA is a standardised criterion reference tool used
to provide information about neurological, postural,
sensory, fine and gross motor performance suitable for
clinical and research applications/environments. It
classifies performance as normal, minimal, mild,
moderate and severe motor dysfunction. The NSMDA
was designed to allow longitudinal follow-up of children
in high-risk groups [10]. It can predict movement
performance in typically developing children from 8
months to 6 years [10–13], and provides information
about function and activity as described by the
International Classification of Functioning, Disability and
Health (ICF) framework [14]. The profile of performance
and response provided by NSMDA can be used to assist
with the diagnosis ,  as  well  as  providing the
physiotherapist with guidance for designing the most
appropriate programme to address the child’s gross and
fine motor activity limitations.
It has been established that the NSMDA 8-month
test age is the optimal age for accurately discriminating
between children who demonstrated normal or
abnormal developmental status [11]. Hence, as this
present study has involved the longitudinal follow-up
of prematurely born children with CP, evaluation of their
performance on the NSMDA at the specified test ages of
8, 12, 24 and 48 months was undertaken. Furthermore,
these test ages are commonly used in follow-up clinics
of high-risk infants.
Reassessment using NSMDA for an individual child
can provide an indication of maintenance, improvement
or deterioration in function and activity up to 6 years of
age [13]. Thus, if applied to large cohorts of children, it
may be possible to provide an indication of the possible
prognosis for children with a certain diagnosis over time.
The aims of this study were to (1) explore the effect
of gender on gestational age (GA), birthweight (BW)
and NSMDA classification at each test age; (2) examine
all the biological variables on walking ability at the age
of 4 years; (3) find if the performance and subsequent
classification on the NSMDA in prematurely born
children with CP at the test age of 8 months can predict
NSMDA performance and subsequent classification at
12 months, and whether classification at 12 months can
predict NSMDA performance and subsequent
classification at 24 months, and whether classification
at 24 months can predict NSMDA performance and
subsequent classification at 4 years; (4) investigate the
percentage of children within each NSMDA classification
at each test age who were walking independently
without any aid at the age of 4 years.
The corresponding alternate hypotheses were that:
(1) there will be an effect of gender on BW and GA and
NSMDA classification at each test age; (2) gender, BW
and GA will have an effect on the walking ability at the
age of 4 years; (3) performance on the NSMDA and
subsequent classification in prematurely born children
with CP at 8 months will predict NSMDA performance
and subsequent classification at 12 months, and that
classification at 12 months will predict NSMDA per-
formance and subsequent classification at 24 months,
and that classification at 24 months will predict NSMDA
performance and subsequent classification at the age of
4 years.
Methods
Subjects
Forty-three children were included in this study and
were followed as a part of a routine follow-up protocol
from 8 months to 4 years. Up to the 2 years age-point,
there was a loss of one child from the total cohort of
children at the 8-month follow-up assesment, one from
the 12-month follow-up assessment, and 3 children from
the 24-month assessment (Figure). All had a history of
premature birth (< 33 weeks’ gestation), very low BW
(< 1,500 g) and a diagnosis of CP given by the age of 4
years. This group included 27 males and 16 females, with
a mean GA of 26.8 ( 2.1 weeks (range, 24–32 weeks)
and a mean BW of 881 ( 228.9 g (range, 493–1,450 g).
The males had a mean BW of 889.33 g and a mean
GA of 26.96 weeks, whereas females had a mean BW of
866.94 g and a mean GA of 26.75 weeks. At the age of
4 years, 35 children displayed independent walking
without any aid. These high-risk infants were from the
large cohort of infants born during 1977–1996 and cared
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for in the Neonatal Intensive Care Unit of the Mater
Mothers’ Hospital, in Brisbane, Australia. All children
received therapy intervention in their local area.
Independent of their local services, this cohort of
children were followed prospectively as part of the
standard practice by a multidisciplinary team and over
a period of 4 years by the Growth & Development
Research Unit (G&DRU), at Mater Mothers’ Hospital.
Therefore, it should be noted that the predictive ability
of the NSMDA for this group of prematurely born
children with CP is dependent upon the context that all
these children had access to therapy intervention.
Instrumentation
The NSMDA evaluates six developmental areas: gross
and fine motor function, neurological status, infant
patterns of movement, postural development and motor
responses to sensory input [15]. In each area, item scores
were used to provide a functional grade. An overall
NSMDA functional score was then determined by the
total of the functional grades in each of the six areas.
Using the overall NSMDA score, children were classified
into groups representing normal function (score of 6–
8); minimal motor dysfunction (score of 9–11); mild
motor dysfunction (score of 12–14); moderate motor
dysfunction (score of 15–19) and severe motor
dysfunction (score of 20 and above).
Procedures
Each child was assessed by a physiotherapist from
G&DRU at 8, 12, 24 and 48 months (age corrected for
prematurity) using the NSMDA. On all assessment
occasions, physiotherapists were blinded to the neonatal
history and any previous medical and developmental
test information. There was a loss of one child from the
total cohort of children at the 8- and 12-month follow-
up assessment, and three children did not attend the
24-month assessment.
Data analysis
An ANOVA was used to explore the effect of gender
on BW and GA, and the effect of BW and GA upon
independent walking at 4 years-of-age. The Pearson’s
Chi-squared test was undertaken to examine the effect
of gender upon NSMDA classification at each test age
and on independent walking at 4 years-of-age. An
ordinal logistic regression was used to examine the
predictive value of NSMDA classification from each test
age from one time to another, using an adjustment
model based on the previous scores. BW, GA and
gender were considered as co-variates. An adjustment
model based on the previous scores was included so as
to ensure that any change in the performance on the
NSMDA from one test age to another was not affected
by the biological factors of BW, GA and gender. Finally,
the percentage of children in each classification at each
age who achieved independent walking at 4 years was
calculated.
Results
Gender, gestational age and birth weight
No significant gender differences were found with respect
to GA (F(1,41)
 
= 0.09, p = 0.76) and BW (F(1,41) = 0.09,
p = 0.76). There were no significant differences between
walkers and non-walkers at the age of 4 years with
respect to GA (F(1,41)
 
= 0.78, p = 0.38), BW (F(1,41)
 
= 1.60,
p = 0.20) and gender (r2(1)
 
= 0.627, p = 0.428). No
significant gender differences were found in NSMDA
classification at 8 months (r2(5)
 
= 7.8, p = 0.180),
12 months (r2(5)
 
= 2.8, p = 0.729), 24 months (r2(4)
 
= 2.8,
p = 0.596) or at 4 years (r2(3)
 
= 2.1, p = 0.544).
Predicting NSMDA classification
NSMDA scores were examined over the four assessment
ages. The Figure provides an overview of the number of
children, who, according to their NSMDA scores,
achieved normal functioning, or minimal, mild,
moderate and severe motor dysfunction over the four
assessment times. As shown in the Figure, there was a
loss of one child from the total cohort of children at the
8- and 12-month follow-up assessment, and three
children did not attend the 24-month assessment.
Figure. Percentage of children gaining specified NSMDA
score/categories from 8–48 months changes over time.
NSMDA = neuro-sensory motor developmental assessment;
normal = normal functioning (NSMDA total score 6–8);
minimal = minimal disability (NSMDA total score 9–11);
mild = mild disability (NSMDA total score 12–14); moderate
disability (NSMDA total score 15–19); severe disability
(NSMDA total score * 20).
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Regression of the NSMDA scores showed that the
classification at 8 months was predictive of the
classification at 12 months (r2(1)
 
= 10.3, p = 0.001, OR =
2.6, 95% CI = 1.45, 4.66). After regression adjustment
for NSMDA scores for 8 months, classification at 12
months predicted NSMDA classification at 2 years
(r2(1)
 
= 12.2, p = 0.000, OR = 4.15, 95% CI = 1.86, 9.2).
Furthermore, after adjustment for previous NSMDA
scores at 8 and 12 months, respectively, the classification
at 2 years predicted NSMDA classification at 4 years
(r2(1)
 
= 8.2, p = 0.004, OR = 4.7, 95% CI = 1.63, 13.87).
The regression adjustment for previous NSMDA scores
at 8 and 12 months showed that there is no evidence to
support the premise that BW, GA, or gender affected
the change in the performance on the NSMDA from
one test age to another.
Predicting walking at the age of 4
All children classified as having normal performance,
minimal or mild difficulties at 12 months of age were
independently walking at 4 years, whereas only 50% of
the children in the severe classification at 12 months of
age achieved independent walking at 48 months (Table).
When interpreting the data, it must be noted that some
children would have changed the classification between
the ages at which they were tested. As an aid to
interpretation, all children in the normal classification
at 8 months were walking independently at the age of
4 years, while only 50% of those who were in the severe
classification at 12 and 24 months were walking
independently at 4 years. Similarly when placed in the
severe classification at 4 years, only 17% were walking
independently. All children who were classified as
normal, or as having a minimal or mild motor
dysfunction at 12 months or as having a minimal motor
dysfunction at 24 months were walking independently
at 4 years. In addition, 93% of the children classified
with a mild motor dysfunction at 24 months and 80%
of children classified with a moderate motor dysfunction
at 24 months were walking independently at 4 years.
Discussion
The results of the study showed that gender had no effect
upon BW, GA and NSMDA classification at each test
age of this group of prematurely born children with CP,
thereby challenging the initial hypothesis of this study.
In addition, the results challenged the study’s second
hypothesis as biological factors of gender, BW and GA
were not predictive of walking outcome for this cohort
of children with CP at 4 years. However, results did
support the third hypothesis that the children’s
performance on the NSMDA at 8 months predicted
classification at 12 months, that the 12-month NSMDA
classification predicted 24-month NSMDA classification,
and that the 24-month classification predicted NSMDA
classification at 4 years.
The NSMDA may be used to assist physiotherapists
working with children who have CP with a history of
low BW and premature birth in predicting possible
functional outcome at the age of 4 years. Therefore, the
NSMDA can be used to assist clinical practice for children
less than 2 years-of-age. In addition, the NSMDA as an
assessment tool for infants and young children with CP
enables the physiotherapist to develop a predictive
profile of the child’s functional abilities, which is based
on the overall performances and responses and not
limited only to the child’s gross motor ability. The
predictive ability of the NSMDA for children with CP
enables physiotherapists and families with the possibility
of providing an intervention that considers the
individual’s sensory motor, postural and neurological
status, for each child, as well as their functional
performance and likely activity limitations.
Interestingly, the Figure indicates a gradual increase
in the percentage of children with a moderate degree of
motor dysfunction on the NSMDA at the 4-year
assessment. In view of the increasingly more complex
gross and fine motor activities undertaken by young
children which demand greater adaptive variability of
movement and greater postural control, it is not
Table. Percentage of children from each NSMDA category who were walking independently at 48 months
Age at assessment Normal Minimal Mild Moderate Severe
(Mo) %(n) %(n) %(n) %(n) %(n)
8 (n = 42) 100 (1) 89 (8) 91 (10) 77 (13) 67 (2)
12 (n = 42) 100 (1) 100 (9) 100 (12) 69 (9) 50 (3)
24 (n = 40) - 100 (5) 93 (14) 80 (12) 50 (2)
48 (n = 43) - 100 (5) 100 (11) 86 (18) 17 (1)
NSMDA = neuro-sensory motor developmental assessment; normal = normal functioning (NSMDA total score 6–8); minimal = minimal disability
(NSMDA total score 9–11); mild = mild disability (NSMDA total score12–14); moderate disability (NSMDA total score 15–19); severe disability
(NSMDA total score * 20).
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surprising that some of these children with CP were re-
classified in the grouping, which indicated increased
motor dysfunction.
The cohort of children with CP in this study
demonstrated a range of very low BWs. Decreasing GA
at delivery and low BW is strongly associated with CP
[4]; however, in this study, GA and BW did not provide
any prognostic insight into the overall functional
performance of these children, as there were no
significant differences between walkers and non-walkers
at 4 years with respect to GA, BW and gender. Caution
must be taken while interpreting these results, as only
limited numbers may have contributed to this picture.
All the children with CP who were classified on the
NSMDA at 12 months as normal, or, having minimal or
mild motor dysfunction were walking independently at
4 years-of-age. At the 12-month assessment, 69.2% of
children classified as having a moderate motor
dysfunction were walking independently by the age of
4 years; however, 80% of the children classified with a
moderate motor dysfunction at the 24-month assessment
were walking independently at 4 years. Only 50% of the
children classified at the 12- and 24-month assessment
as having a severe motor dysfunction were walking
independently at 4 years. Caution must be applied,
however, when considering NSMDA classification at 12
and 24 months and independent walking at 4 years, due
to the small number of children classified as having a
severe motor dysfunction within this study at 12 and
24 months. The predictive information about the
walking ability of children with CP from our study may
assist physiotherapists in their communication with
families. Families are often anxiously awaiting some
prognostic information regarding their child’s likely
functional capacity. Indeed, families are particularly
interested in their child’s likely functional performance
at 4 years-of-age when their child would be entering a
preparatory school setting. Hence, predictive information
about independent walking for these children with CP
will enable physiotherapists to establish realistic goals
and work towards the management of the child and its
family. Indeed, Lin suggests that lack of understanding
of walking prognosis may result in inappropriate care
and frustration [16].
A limitation of this study relates to the relatively small
number of children with CP born prematurely at this
hospital during the study period. A multi-centred trial,
which would have access to larger numbers of infants
and young children born prematurely, would enable a
greater overview of this population of children’s
performance at 8, 12, 24 and 48 months-of-age.
Furthermore, a potential limitation to the findings of
this study is the loss of one child from the total cohort
of children at the 8- and 12-month follow-up asses-
sment, and the loss of three children from the cohort
at the 24-month assessment time.
In view of the geographical nature of the region
where these children reside, the loss to follow-up was
relatively minor. Indeed, the follow-up of these children
was undertaken by a research group based in Brisbane,
and these children and their families resided throughout
the greater Queensland and Northern New South Wales
regions. It should be noted, therefore, that, although a
small number of children did not attend follow-up in
Brisbane at each test age, all children would have had
access to therapy intervention in their local region.
Conclusion
The most important finding of this study was that, for
this group of prematurely-born children with CP,
NSMDA classification at 8 months predicted classification
at 12 months; that, at 12 months, NSMDA classification
predicted the classification at 24 months; and that, at
24 months, classification predicted NSMDA classification
at 4 years. Furthermore, this study was able to provide
predictive walking information about our cohort of
infants and young children with CP. Hence, the NSMDA
can be used as a predictive tool by physiotherapists
working with children of very low BW and premature
birth and with CP. The NSMDA can be seen, therefore,
as adding a further tool to be used in clinical practice.
The NSMDA may be part icular ly  useful  for
physiotherapists working with infants and children who
are less than 2 years old. An advantage of this NSMDA
tool is that it provides a comprehensive profile, providing
information about the neurological, postural, sensory,
fine and gross motor performance of each child. It is
important that further research with the NSMDA
confirm the findings in this study and improve the
understanding of this population of children’s movement
during infancy and early childhood.
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